Skip to content

Geron Corp

GERN· NasdaqCore metricsCIK 886744

Pharmaceutical preparations552 peers

Last sale
Nov 6, 2026 · +3.98%
Market cap
$636.38M
644.24M shares
Filings
1,013
$60.19M
Q3 2026−60.2% FY23 yoy
$1.35M
Q3 2026N/M FY25 yoy
$5.80M
Q3 2026N/M FY25 yoy
-$219.30M
FY 2024derivedN/M FY24 yoy
$0.00
Q3 2026N/M FY25 yoy
$69.18M
Q3 2026−1.8% FY25 yoy
$636.38M
—
—
2.8×
—
—

FY2025 figures · derived

Price

$0.98789.38%$0.1022past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$237.00KFY 2023
$36.37M0FY 2012FY 2017FY 2023
PeriodEndedValueKindSource trail
FY 20232023-12-31$237,000reported
FY 20222022-12-31$596,000reported
FY 20212021-12-31$1,393,000reported
FY 20202020-12-31$253,000reported
FY 20192019-12-31$460,000reported
FY 20182018-12-31$1,066,000reported
FY 20172017-12-31$1,065,000reported
FY 20162016-12-31$6,162,000reported
FY 20152015-12-31$36,371,000reported
FY 20142014-12-31$1,153,000reported
FY 20132013-12-31$1,283,000reported
FY 20122012-12-31$2,709,000reported

Capital returns

Dividends and buybacks · FY2013 to FY2015
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2015$0.00—$0.00—158.92M sh+0.8%—
FY2014$0.00—$0.00—157.70M sh+0.5%0.0%
FY2013$0.00—$0.00—156.90M sh+20.2%—

Segments

Products
Revenue by Products, FY2022 to FY2025FY2022Other · FY2022 · $596.00KFY2023Royalties · FY2023 · $237.00KOther · FY2023 · $237.00KFY2024Revenues Before Adjustments · FY2024 · $89.42MProduct revenues, net · FY2024 · $76.50MRoyalties · FY2024 · $499.00KFY2025Revenues Before Adjustments · FY2025 · $223.11MProduct revenues, net · FY2025 · $183.62MRoyalties · FY2025 · $258.00K
LineFY2025ShareChange
Revenues Before Adjustments$223.11M55%+149.5%
Product revenues, net$183.62M45%+140.0%
Royalties$258.00K0.1%−48.3%
Government Rebates-$2.60M—N/M
Sales Returns And Allowance-$3.85M—N/M
Distributor service fees-$7.51M—N/M
Chargebacks-$25.53M—N/M
Other-$39.49M—N/M
Total$406.99M

From the 10-K filed Mar 2, 2026GERN

Pharmaceutical preparations

Geron Corp is the 172nd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Geron Corp · CIK 886744 · Engraved from SEC EDGAR